Biolase (BIOL +28%) soars after the FDA approves it's Diolase 10 diode soft tissue laser for a...
Biolase (BIOL +28%) soars after the FDA approves it's Diolase 10 diode soft tissue laser for a broad spectrum of over 80 procedures in 18 different medical markets, including pulmonary and vascular surgery. The company's diode lasers are primarily used in dentistry for surgical soft tissue procedures as an alternative to invasive and traumatic conventional devices, such as the high-speed drill or scalpel, and the approval significantly expands its potential for new markets.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs